Kate Bak
Kate Bak
Policy Research Analyst
Verified email at cancercare.on.ca
Title
Cited by
Cited by
Year
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline
DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ...
J Clin Oncol 32 (18), 1941-1967, 2014
9752014
Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation
BL Andersen, RJ DeRubeis, BS Berman, J Gruman, VL Champion, ...
Journal of Clinical Oncology 32 (15), 1605, 2014
5132014
Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation
JE Bower, K Bak, A Berger, W Breitbart, CP Escalante, PA Ganz, ...
Journal of clinical oncology 32 (17), 1840, 2014
4722014
Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma
S Verma, I Quirt, D McCready, K Bak, M Charette, N Iscoe, ...
Cancer 106 (7), 1431-1442, 2006
1612006
Temozolomide for the treatment of metastatic melanoma: a systematic review
I Quirt, S Verma, T Petrella, K Bak, M Charette
The oncologist 12 (9), 1114-1123, 2007
1412007
Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review
T Petrella, I Quirt, S Verma, AE Haynes, M Charette, K Bak, ...
Cancer treatment reviews 33 (5), 484-496, 2007
1122007
Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review
C Hamm, S Verma, T Petrella, K Bak, M Charette, ...
Cancer treatment reviews 34 (2), 145-156, 2008
802008
American Society of Clinical O. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology …
DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ...
J Clin Oncol 32 (18), 1941-67, 2014
592014
Single-agent interleukin-2 in the treatment of metastatic melanoma
T Petrella, I Quirt, S Verma, AE Haynes, M Charette, K Bak, ...
Current Oncology 14 (1), 21, 2007
412007
Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
S Verma, T Petrella, C Hamm, K Bak, M Charette, ...
Current Oncology 15 (2), 85, 2008
382008
Temozolomide for the treatment of metastatic melanoma
I Quirbt, S Verma, T Petrella, K Bak, M Charette, ...
Current Oncology 14 (1), 27, 2007
372007
Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario
A Whitton, P Warde, M Sharpe, TK Oliver, K Bak, K Leszczynski, ...
Clinical Oncology 21 (3), 192-203, 2009
262009
American Society of Clinical Oncology Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice …
JE Bower, K Bak, A Berger, W Breitbart, CP Escalante, PA Ganz, ...
J Clin Oncol 32 (17), 1840-1850, 2014
222014
American Society of Clinical O. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline …
BL Andersen, RJ DeRubeis, BS Berman, J Gruman, VL Champion, ...
J Clin Oncol 32 (15), 1605-19, 2014
212014
A roadmap for change: charting the course of the development of a new, advanced role for radiation therapists
N Harnett, K Bak, L Zychla, E Lockhart
Journal of allied health 43 (2), 110-116, 2014
192014
The Clinical Specialist Radiation Therapist (CSRT): A case study exploring the effectiveness of a new advanced practice role in Canada
N Harnett, K Bak, E Lockhart, M Ang, L Zychla, E Gutierrez, P Warde
Journal of medical radiation sciences 65 (2), 86-96, 2018
182018
Hindsight is 20/20: Lessons learned after implementing experience based design
K Bak, L Macdougall, E Green, L Moody, G Obarski, L Hale, S Boyko, ...
Patient Experience Journal 1 (2), 12-19, 2014
172014
Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada
K Bak, MJ Dobrow, D Hodgson, A Whitton
BMC health services research 11 (1), 1-11, 2011
152011
Defining advanced practice in radiation therapy: A feasibility assessment of a new healthcare provider role in Ontario, Canada
N Harnett, K Bak, L Zychla, E Gutierrez, P Warde
Radiography 25 (3), 241-249, 2019
112019
Melanoma Disease Site Group of Cancer Care OntarioLs Program in Evidence-based Care. Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review
C Hamm, S Verma, T Petrella, K Bak, M Charette
Cancer Treat Rev 34 (2), 145-156, 2008
112008
The system can't perform the operation now. Try again later.
Articles 1–20